Sashika Harasgama
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sashika Harasgama has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Amy Dehn Lunn
Wolfson Institute for Population Health, Queen Mary University of London, UK
6 shared publications - Helen Pearce
Wolfson Institute for Population Health, Queen Mary University of London, UK
6 shared publications - Helena Painter
Queen Mary University of London
6 shared publications - John Ford
Wolfson Institute of Population Health, Queen Mary University of London, London, UK
6 shared publications - Adnaan Ghanchi
Department of Public Health and Primary Care, University of Cambridge, UK
5 shared publications - Anna Gkiouleka
Wolfson Institute for Population Health, Queen Mary University of London, UK
4 shared publications
Latest Publications
- Open Access
- 19 May 2026
- Published by Elsevier in Public Health in Practice
What works to support people from disadvantaged backgrounds return to work: A policy-focused evidence brief
- 19 May 2026
- Published by Elsevier in Public Health in Practice
Open AccessWhat works to support people from disadvantaged backgrounds return to work: A policy-focused evidence brief
- Open Access
- 9 May 2026
- Published by Elsevier in Public Health in Practice
- Vol. 11, 100808
What works to improve health and digital health literacy in disadvantaged groups: A policy-focused evidence brief
- 9 May 2026
- Published by Elsevier in Public Health in Practice
- Vol. 11, 100808
Open AccessWhat works to improve health and digital health literacy in disadvantaged groups: A policy-focused evidence brief
- Top Cited PapersOpen Access
- 30 March 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28 (1) , e81597
Artificial Intelligence Tools for Automating Evidence Synthesis: Scoping Review
Background: Rapidly and accurately synthesizing large volumes of evidence is a time- and resource-intensive process. Once published, reviews often risk becoming outdated, limiting their usefulness for decision makers. Recent advancements in artificial intelligence (AI) have enabled researchers to automate stages of the evidence synthesis process, from literature searching and screening to data extraction and analysis. As previous reviews on this topic have been published, a significant number of tools have been further developed and evaluated. Furthermore, as generative AI increasingly automates evidence synthesis, understanding how it is studied and applied is crucial, given both its benefits and risks. Objective: This review aimed to map the current landscape of evaluated AI tools used to automate evidence synthesis. Methods: Following the Joanna Briggs Institute methodology for scoping reviews, we searched Ovid MEDLINE, Ovid Embase, Scopus, and Web of Science in February 2025 and conducted a gray literature search in April 2025. We included articles published in any language from January 2021 onward. Two reviewers independently screened citations using Rayyan, and data were extracted based on study design and key AI-related technical features. Results: We identified 7841 unique citations through database searches and 19 records through gray literature searching. A total of 222 articles were included in the review. We identified 65 AI tools and 25 open-source models or machine learning (ML) algorithms that automate parts of or the whole evidence synthesis pathway. A total of 54.1% (n=120) of the studies were published in 2024, reflecting a trend toward researching general-purpose large language models (LLMs) for evidence synthesis automation. The most popular tool studied was generative pretrained transformer models, including its conversational interface ChatGPT (n=70, 31.5%). Moreover, 31.1% (n=69) studied tools automated by traditional ML algorithms. No studies compared traditional ML tools to LLM-based tools. In addition, 61.7% (n=137) and 26.1% (n=58) studied AI-assisted automation of title and abstract screening and data extraction, respectively, the 2 most intensive stages and, therefore, amenable to automation. Technical performance outcomes were the most frequently reported, with only 4.1% (n=9) of studies reporting time- or workload-specific outcomes. Few studies pragmatically evaluated AI tools in real-world evidence synthesis settings. Conclusions: This review comprehensively captures the broad, evolving suite of AI automation tools available to support evidence synthesis, leveraged by increasingly complex AI approaches that range from traditional ML to LLMs. The notable shift toward studying general-purpose generative AI tools reflects how these technologies are actively transforming evidence synthesis practice. The lack of studies in our review comparing different AI approaches for specific automation stages or evaluating their effectiveness pragmatically represents a significant research gap. Optimal tool selection will likely depend on the review topic and methodology and researcher priorities. While they offer potential for reducing workload, ongoing evaluation to mitigate AI bias and to ensure the integrity of reviews is essential for safeguarding evidence-based decision-making.
- 30 March 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28 (1) , e81597
Top Cited PapersOpen AccessArtificial Intelligence Tools for Automating Evidence Synthesis: Scoping Review
Background: Rapidly and accurately synthesizing large volumes of evidence is a time- and resource-intensive process. Once published, reviews often risk becoming outdated, limiting their usefulness for decision makers. Recent advancements in artificial intelligence (AI) have enabled researchers to automate stages of the evidence synthesis process, from literature searching and screening to data extraction and analysis. As previous reviews on this topic have been published, a significant number of tools have been further developed and evaluated. Furthermore, as generative AI increasingly automates evidence synthesis, understanding how it is studied and applied is crucial, given both its benefits and risks. Objective: This review aimed to map the current landscape of evaluated AI tools used to automate evidence synthesis. Methods: Following the Joanna Briggs Institute methodology for scoping reviews, we searched Ovid MEDLINE, Ovid Embase, Scopus, and Web of Science in February 2025 and conducted a gray literature search in April 2025. We included articles published in any language from January 2021 onward. Two reviewers independently screened citations using Rayyan, and data were extracted based on study design and key AI-related technical features. Results: We identified 7841 unique citations through database searches and 19 records through gray literature searching. A total of 222 articles were included in the review. We identified 65 AI tools and 25 open-source models or machine learning (ML) algorithms that automate parts of or the whole evidence synthesis pathway. A total of 54.1% (n=120) of the studies were published in 2024, reflecting a trend toward researching general-purpose large language models (LLMs) for evidence synthesis automation. The most popular tool studied was generative pretrained transformer models, including its conversational interface ChatGPT (n=70, 31.5%). Moreover, 31.1% (n=69) studied tools automated by traditional ML algorithms. No studies compared traditional ML tools to LLM-based tools. In addition, 61.7% (n=137) and 26.1% (n=58) studied AI-assisted automation of title and abstract screening and data extraction, respectively, the 2 most intensive stages and, therefore, amenable to automation. Technical performance outcomes were the most frequently reported, with only 4.1% (n=9) of studies reporting time- or workload-specific outcomes. Few studies pragmatically evaluated AI tools in real-world evidence synthesis settings. Conclusions: This review comprehensively captures the broad, evolving suite of AI automation tools available to support evidence synthesis, leveraged by increasingly complex AI approaches that range from traditional ML to LLMs. The notable shift toward studying general-purpose generative AI tools reflects how these technologies are actively transforming evidence synthesis practice. The lack of studies in our review comparing different AI approaches for specific automation stages or evaluating their effectiveness pragmatically represents a significant research gap. Optimal tool selection will likely depend on the review topic and methodology and researcher priorities. While they offer potential for reducing workload, ongoing evaluation to mitigate AI bias and to ensure the integrity of reviews is essential for safeguarding evidence-based decision-making.
- Open Access
- 26 March 2026
- Published by Elsevier in Public Health in Practice
- Vol. 11, 100780
Improving behavioural interventions in healthcare to address the needs of disadvantaged groups: A policy-focused evidence brief
- 26 March 2026
- Published by Elsevier in Public Health in Practice
- Vol. 11, 100780
Open AccessImproving behavioural interventions in healthcare to address the needs of disadvantaged groups: A policy-focused evidence brief
- Open Access
- 20 March 2026
- Published by Elsevier in Public Health in Practice
- Vol. 11, 100773
Community engagement and empowerment to address health inequalities: A rapid evidence review
- 20 March 2026
- Published by Elsevier in Public Health in Practice
- Vol. 11, 100773
Open AccessCommunity engagement and empowerment to address health inequalities: A rapid evidence review
- Open Access
- 20 March 2026
- Published by Elsevier in Public Health in Practice
- Vol. 11, 100774
Empowering health care staff to address health inequalities: A policy-focused evidence brief
- 20 March 2026
- Published by Elsevier in Public Health in Practice
- Vol. 11, 100774
Open AccessEmpowering health care staff to address health inequalities: A policy-focused evidence brief
- 2 March 2026
- Published by Elsevier in Public Health
- Vol. 254, 106220
An overview of artificial intelligence approaches for automating evidence synthesis
- 2 March 2026
- Published by Elsevier in Public Health
- Vol. 254, 106220
An overview of artificial intelligence approaches for automating evidence synthesis
- Open Access
- 19 February 2026
- Published by Elsevier in Public Health in Practice
- Vol. 11, 100756
Payment mechanisms to improve prevention spending in health care settings: A policy-focused evidence brief
- 19 February 2026
- Published by Elsevier in Public Health in Practice
- Vol. 11, 100756
Open AccessPayment mechanisms to improve prevention spending in health care settings: A policy-focused evidence brief
- Open Access
- 1 August 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Artificial intelligence tools for automating evidence synthesis: A scoping review (Preprint)
BACKGROUND Rapidly and accurately synthesizing large volumes of evidence is a time and resource-intensive process. Once published, reviews often risk becoming outdated, limiting their usefulness for decision-makers. Recent advancements in artificial intelligence (AI) have enabled researchers to automate various stages of the evidence synthesis process, from literature searching and screening to data extraction. OBJECTIVE We aimed to map the current landscape of AI tools used to automate evidence synthesis. METHODS Following the JBI methodology for scoping reviews, we searched Ovid MEDLINE, Ovid Embase, Scopus, and Web of Science in February 2025, and conducted a grey literature search in April 2025. We included articles published in any language from January 2021 onwards. Two reviewers independently screened citations using Rayyan, and we extracted data based on study design and key AI-related technical features. RESULTS We identified 7,841 unique citations through database searches and 19 additional records through a grey literature search. A total of 222 articles were included in the review. We identified 65 AI tools that automate either specific tasks or the entire evidence synthesis process. More than half of the included studies were published in 2024, reflecting a trend in the use of general-purpose large language models (LLMs) for evidence synthesis. Title and abstract screening, as well as data extraction, were the most studied tasks for automation. CONCLUSIONS A broad, evolving suite of AI tools is available to support automation in evidence synthesis, leveraged by increasingly complex AI methods. Optimal tool selection likely will depend on the review topic, researcher priorities, and specific tasks. While these tools offer potential for reducing manual workload, ongoing evaluation to mitigate AI bias, and ensure quality and integrity of reviews, is essential for safeguarding evidence-based decision-making.
- 1 August 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessArtificial intelligence tools for automating evidence synthesis: A scoping review (Preprint)
BACKGROUND Rapidly and accurately synthesizing large volumes of evidence is a time and resource-intensive process. Once published, reviews often risk becoming outdated, limiting their usefulness for decision-makers. Recent advancements in artificial intelligence (AI) have enabled researchers to automate various stages of the evidence synthesis process, from literature searching and screening to data extraction. OBJECTIVE We aimed to map the current landscape of AI tools used to automate evidence synthesis. METHODS Following the JBI methodology for scoping reviews, we searched Ovid MEDLINE, Ovid Embase, Scopus, and Web of Science in February 2025, and conducted a grey literature search in April 2025. We included articles published in any language from January 2021 onwards. Two reviewers independently screened citations using Rayyan, and we extracted data based on study design and key AI-related technical features. RESULTS We identified 7,841 unique citations through database searches and 19 additional records through a grey literature search. A total of 222 articles were included in the review. We identified 65 AI tools that automate either specific tasks or the entire evidence synthesis process. More than half of the included studies were published in 2024, reflecting a trend in the use of general-purpose large language models (LLMs) for evidence synthesis. Title and abstract screening, as well as data extraction, were the most studied tasks for automation. CONCLUSIONS A broad, evolving suite of AI tools is available to support automation in evidence synthesis, leveraged by increasingly complex AI methods. Optimal tool selection likely will depend on the review topic, researcher priorities, and specific tasks. While these tools offer potential for reducing manual workload, ongoing evaluation to mitigate AI bias, and ensure quality and integrity of reviews, is essential for safeguarding evidence-based decision-making.